Supplementary table II - Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
收藏Mendeley Data2024-03-27 更新2024-06-26 收录
下载链接：
https://data.mendeley.com/datasets/8mbpb6snwz
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary table II: Dupilumab dose optimization and discontinuation.
创建时间：
2024-01-23
